Welcome to the Recombinant Antibody Network

The Recombinant Antibody Network is a consortium of highly integrated technology centers at UCSF, the University of Chicago, and the University of Toronto, unified under a common goal to generate therapeutic grade recombinant antibodies at a proteome wide scale for biology and biomedicine.

Given that over half the human proteome is not annotated and that functional antibodies are not reliably available, a complete set of validated antibodies would greatly advance all areas of biology, including cancer therapy and infectious disease control. To undertake these challenges, RAN is systematically and comprehensively profiling families of protein targets using novel, modern high-throughput in vitro technology.

Latest Publications

Clarifying Frizzled 2 function in development through genetically validated mouse models

Michalski M N; Diegel C R; Zhong Z A; Marshall M E; Wiartalla G E F; Stevens P D; Suino-Powell K; Blazer L L; Adams J J; Melcher K; Sidhu S S; Angers S; Williams B O

Clarifying Frizzled 2 function in development through genetically validated mouse models Journal Article

In: Dis Model Mech, vol. 19, no. 7, 2026, ISSN: 1754-8411.

Abstract | Links

A  designed enzyme for photo-proximity labeling of E3 ligase neighborhoods in live cells

Kim N H; Lin Z; Nam S; Swaney D L; Krogan N; Kim Y H; Therien M J; DeGrado W F; Wells J A

A designed enzyme for photo-proximity labeling of E3 ligase neighborhoods in live cells Journal Article

In: bioRxiv, 2026, ISSN: 2692-8205.

Abstract | Links

Epitope-guided detection of a molecular glue-induced ternary complex using engineered synthetic antibody fragments

O'Leary K M; Slezak T; Le D A; Kossiakoff A A

Epitope-guided detection of a molecular glue-induced ternary complex using engineered synthetic antibody fragments Journal Article

In: J Mol Biol, pp. 169953, 2026, ISSN: 1089-8638.

Abstract | Links

Latest News

Scroll to Top